Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 7.16
-0.05 (-0.69%)
Oct 19, 2026, 2:49 PM CET
Vivesto AB Market Cap
Vivesto AB has a market cap or net worth of 79.27 million as of October 19, 2026. It is the 42,763rd most valuable company in the world and the 627th biggest in Sweden. Its market cap has decreased by 36.36% in one year.
Market Cap
79.27M
Enterprise Value
55.76M
Revenue
n/a
Global Rank
Country Rank
#627 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since August 11, 2006, Vivesto AB's market cap has decreased from 1.15B to 79.27M, a decrease of -93.11%. That is a compound annual growth rate of -12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 79.27M | 9.13% |
| Dec 30, 2025 | 72.64M | -53.45% |
| Dec 30, 2024 | 156.03M | -28.83% |
| Dec 29, 2023 | 219.25M | -6.11% |
| Dec 30, 2022 | 233.51M | -80.14% |
| Dec 30, 2021 | 1.18B | -36.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.14B |
| Dicot Pharma AB | 776.99M |
| EQL Pharma AB | 649.65M |
| Cinclus Pharma Holding AB | 588.24M |
| Moberg Pharma AB | 530.31M |
| Enzymatica AB | 461.20M |
| Orexo AB | 219.49M |
| Klaria Pharma Holding AB (publ.) | 127.17M |